joint pain on retatrutide Side Effects: What Clinical Trials Tell Us TRIUMPH-4: Retatrutide Delivers Weight Loss,

GLP-1

Contrave: Nausea, constipation, headache, insomnia Increased blood pressure and heart rate Other effects: anxiety, dizziness, dry mouth, tremors, risk of seizures in susceptible individuals Serious risks: liver problems, severe allergic reactions, neuropsychiatric events, including mood changes or suicidal thoughts Wegovy: Gastrointestinal issues: nausea, vomiting, diarrhea, constipation, abdominal pain Other effects: fatigue, headache, dizziness (especially during dose escalation) Serious risks: pancreatitis, gallbladder disease, thyroid tumors in high-risk patients, increased heart rate Important: Neither medication is a cure for obesity

The rat CRF 2a R contains an uncleaved N-terminal signal peptide, and deletion of this resulted in a significant reduction in its membrane expression, suggesting that receptor transportation was affected (Rutz et al., 2006)

doi: 10.1210/en.2007-1292 57 BunckMCEliassonBCornrAHeineRJShaginianRMTaskinenM-Ret al

In a related context, a large retrospective cohort study using real-world surgical data found no significant association between preoperative GLP-1 RA use and 30-day postoperative aspiration pneumonia 51